COLLEGIUM PHARMACEUTICAL, INC Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $34.8M, a 22.6% decline year-over-year.
  • Collegium Pharmaceutical, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $193M, a 65.3% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2023 was $167M, a 401% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2022 was $33.3M, a 89% increase from 2021.
  • Collegium Pharmaceutical, Inc annual Operating Income (Loss) for 2021 was $17.6M, a 68.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $193M $34.8M -$10.2M -22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $204M $47.5M +$11.8M +33.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $192M $49.5M +$24.8M +101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $167M $61.7M +$49.9M +425% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $117M $45M +$24.5M +120% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $92.5M $35.6M +$24.5M +221% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $68M $24.6M +$34.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $33.3M $11.8M +$45.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$12.6M $20.5M +$6.32M +44.7% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 -$18.9M $11.1M -$5.3M -32.3% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 -$13.6M -$10M -$31.2M -147% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $17.6M -$34.1M -$49.1M -328% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $66.7M $14.1M -$5.48M -27.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $72.2M $16.4M -$140K -0.85% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $72.4M $21.2M +$16.1M +319% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $56.2M $15M +$17.4M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $38.9M $19.6M +$26M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $12.9M $16.5M +$21.6M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$8.7M $5.06M +$15.1M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$23.7M -$2.37M -$13.4M -122% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$10.4M -$6.38M +$4.81M +43% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$15.2M -$5.01M +$2.29M +31.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$17.5M -$9.99M +$3.22M +24.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$20.7M $11M +$28.6M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$49.3M -$11.2M +$2.24M +16.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$51.5M -$7.29M +$14M +65.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$65.5M -$13.2M +$9.97M +43% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$75.4M -$17.6M +$10M +36.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$85.4M -$13.4M +$13M +49.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$98.5M -$21.3M +$3.22M +13.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$102M -$23.2M -$7.59M -48.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$94.1M -$27.6M -$18.1M -192% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$75.9M -$26.4M -$17.2M -185% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$58.8M -$24.5M -$19.9M -435% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$38.9M -$15.6M -$12M -329% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$26.9M -$9.44M -$6.11M -184% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$20.8M -$9.27M -$2.76M -42.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$18M -$4.58M -$487K -11.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$17.6M -$3.63M +$114K +3.04% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$17.7M -$3.33M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$6.51M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$4.09M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$3.75M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.